CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™, today announced it will provide an update on corporate activities for the first-quarter 2015 on May 6.
Christopher D. T. Guiffre, JD, MBA, President and Chief Executive Officer, and Paul Friedman, M.D., Executive Chairman will conduct a conference call at 4:30 p.m. ET that day to provide a business update and review the Company's first-quarter financial results. The call can be accessed by dialing (844) 831-3031 or (443) 637-1284 prior to the start of the call and referencing conference ID 33646103.
Help employers find you! Check out all the jobs and post your resume.
Christopher D. T. Guiffre, JD, MBA, President and Chief Executive Officer, and Paul Friedman, M.D., Executive Chairman will conduct a conference call at 4:30 p.m. ET that day to provide a business update and review the Company's first-quarter financial results. The call can be accessed by dialing (844) 831-3031 or (443) 637-1284 prior to the start of the call and referencing conference ID 33646103.
Help employers find you! Check out all the jobs and post your resume.